Table 4. Initial involvement, relapse... | American Society of Hematology

Table 4.

Initial involvement, relapse localization, time to relapse, and survival in relapse patients

Initial involvement	Stage	Relapse time	Localization	Survival
Med, PL	I	183 d	Lung	1582 d+
Med, LN	II	66 d	Med, LN	335 d
Med, PL, LN	II	395 d	Mamma	1796 d
Med, PL, LN	II	159 d	Med, PL	327 d
Med, LN, Wald	III	134 d	Med	561 d
LN^4-150	III	331 d	BM	489 d
Med, LN, BM, Liver	IV	58 d	BM, CNS	182 d
Med, PL, LN	IV	23 d	Med	185 d
Med, PL, LN, Liver	IV	180 d	LN	379 d
Med, BM	IV	123 d	Med	334 d
Med, PL, LN, Liver	IV	183 d	BM, LN	299 d
Med	IV	81 d	Med, PL	161 d
Med, LN, BM	IV	426 d	Med, PL	761 d
Med, LN, BM	IV	329 d	BM	435 d
Med, LN, BM	IV	60 d	BM, LN	215 d

Initial involvement	Stage	Relapse time	Localization	Survival
Med, PL	I	183 d	Lung	1582 d+
Med, LN	II	66 d	Med, LN	335 d
Med, PL, LN	II	395 d	Mamma	1796 d
Med, PL, LN	II	159 d	Med, PL	327 d
Med, LN, Wald	III	134 d	Med	561 d
LN^4-150	III	331 d	BM	489 d
Med, LN, BM, Liver	IV	58 d	BM, CNS	182 d
Med, PL, LN	IV	23 d	Med	185 d
Med, PL, LN, Liver	IV	180 d	LN	379 d
Med, BM	IV	123 d	Med	334 d
Med, PL, LN, Liver	IV	183 d	BM, LN	299 d
Med	IV	81 d	Med, PL	161 d
Med, LN, BM	IV	426 d	Med, PL	761 d
Med, LN, BM	IV	329 d	BM	435 d
Med, LN, BM	IV	60 d	BM, LN	215 d

Malignant histiocytosis as secondary malignancy.

Med indicates mediastinal tumor; PL, pleura effusion; LN, lymph nodes; Wald, Waldeyer ring; BM, bone marrow; CNS, central nervous system.